Chinese ADC, RNA Therapy Developers Lead May/June Fundraising

 
• By Dexter Jie Yan
  
funding
Antibody-drug conjugates and RNA therapies come to fore as promising assets in China • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia